Teachers Advisors’s Ocular Therapeutix OCUL Stock Holding History

Teachers Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$267K	Hold	67,202	–	–	﹤0.01%	2762
2018 Q4	$267K	Hold	67,202	–	–	﹤0.01%	2749
2018 Q3	$462K	Buy	67,202 +13,061	+24%	+$82K	﹤0.01%	2667
2018 Q2	$365K	Buy	54,141 +11,462	+27%	+$78.8K	﹤0.01%	2796
2018 Q1	$278K	Hold	42,679	–	–	﹤0.01%	2782
2017 Q4	$190K	Hold	42,679	–	–	﹤0.01%	2938
2017 Q3	$264K	Hold	42,679	–	–	﹤0.01%	2891
2017 Q2	$396K	Buy	42,679 +2,500	+6%	+$24.2K	﹤0.01%	2708
2017 Q1	$373K	Buy	40,179 +2,861	+8%	+$23.8K	﹤0.01%	2671
2016 Q4	$312K	Buy	37,318 +12,050	+48%	+$93.5K	﹤0.01%	2756
2016 Q3	$174K	Hold	25,268	–	–	﹤0.01%	2918
2016 Q2	$125K	Buy	25,268 +3,836	+18%	+$38K	﹤0.01%	3018
2016 Q1	$207K	Hold	21,432	–	–	﹤0.01%	2783
2015 Q4	$201K	Buy	21,432 +2,418	+13%	+$26.1K	﹤0.01%	2869
2015 Q3	$267K	Hold	19,014	–	–	﹤0.01%	2751
2015 Q2	$400K	Buy	19,014 +10,707	+129%	+$265K	﹤0.01%	2658
2015 Q1	$349K	Hold	8,307	–	–	﹤0.01%	2642
2014 Q4	$195K	Buy	8,307 +2,948	+55%	+$49.6K	﹤0.01%	2909
2014 Q3	$80K	Buy	+5,359	New	+$79.2K	﹤0.01%	3072

Other funds holding OCUL

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAM

Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Teachers Advisors's OCUL Position: Q1 2019 in Review

Teachers Advisors held its Ocular Therapeutix (OCUL) position steady in Q1 2019 at 67,202 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Teachers Advisors first reported a position in OCUL in Q3 2014 and has held it in 19 quarters since. The position peaked at $462K in Q3 2018. 68 funds tracked by Wall St. Rank hold OCUL as of Q1 2019.

Teachers Advisors held 67,202 shares of Ocular Therapeutix worth $267K as of Q1 2019.
Teachers Advisors left its Ocular Therapeutix share count unchanged in Q1 2019.
Ocular Therapeutix made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2762 holding.
Teachers Advisors first reported a position in Ocular Therapeutix in Q3 2014 and has held it in 19 quarters since.
Teachers Advisors's Ocular Therapeutix position peaked at $462K in Q3 2018.
68 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.